Riskpilot← Back to searchSign inGet full accessSchroll Medical ApS
APSActiveCVR 39467135Kirstinebjergvej 33Manufacture of pharmaceutical preparations · NACE 2120Est. 2018104 employees
Revenue 2025
DKK 98,4M
+111% vs 2024
EBITDA margin
68.5%
+144% vs 2024
Equity ratio
81.9%
Financial strength
Net profit 2025
DKK 40,3M
+454% vs 2024
| Revenue | DKK 98,4M | +111% |
| EBITDA | DKK 67,4M | +144% |
| Net profit | DKK 40,3M | +454% |
| Total assets | DKK 145,8M | +50% |
| Equity | DKK 119,5M | +51% |
| Employees | 104 | — |
Legal name
Schroll Medical ApS
CVR number
39467135
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
6. april 2018
Share capital
DKK 80.000.000
Employees
104 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede
bestyrelse.
Company purpose
Selskabets formål er at producere, forarbejde og sælge planter til medicinsk brug og dermed beslægtet virksomhed.
Address
Kirstinebjergvej 33
Phone
+4526772355
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | -103 | -31 | -187 | 20.215 | 30.414 | 46.615 | 98.362 |
| Staff expenses | -0 | -0 | -3.167 | -14.266 | -15.898 | -18.351 | -28.036 |
| EBITDA | -103 | -31 | -3.354 | 4.949 | 14.373 | 27.643 | 67.426 |
| Depreciation & amort. | -0 | -3.000 | -4.692 | -9.280 | -11.164 | -18.601 | -17.033 |
| EBIT | -103 | -3.031 | -8.046 | -4.331 | 3.209 | 9.042 | 50.393 |
| Net financials | -125 | -173 | -230 | -232 | -181 | 208 | 976 |
| Profit before tax | -227 | -3.204 | -8.276 | -4.563 | 3.028 | 9.250 | 51.368 |
| Tax | -80 | -1.182 | -3.045 | -1.455 | 585 | 1.979 | 11.107 |
| Net profit | -148 | -2.022 | -5.231 | -3.108 | 2.442 | 7.271 | 40.262 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 32.390 | 44.290 | 71.596 | 89.747 | 88.167 | 96.969 | 145.839 |
| Equity | 19.852 | 27.830 | 52.599 | 69.491 | 71.933 | 79.205 | 119.466 |
| Long-term debt | 0 | 625 | 0 | 0 | 629 | 3.681 | 8.158 |
| Short-term debt | 9.926 | 11.022 | 10.557 | 11.270 | 6.663 | 6.844 | 10.527 |
| Total debt | 9.926 | 11.648 | 10.557 | 11.270 | 7.292 | 10.525 | 18.685 |
EBITDA margin
68.5%
This company
15.8%
Market median
+334% vs market
20192025
Equity ratio
81.9%
This company
38.2%
Market median
+114% vs market
20192025
Return on equity
33.7%
This company
18.4%
Market median
+83% vs market
20192025
Net profit margin
40.9%
This company
8.1%
Market median
+405% vs market
20192025
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20192025
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20192025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-04-06 – 2019-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FH Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
CG Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Schroll Medical Holding ApS | Company | 100.0% | 100.0% | 2025 |
| Individual | 5.0% | 5.0% | 2021 | |
Schroll Medical Holding ApS | Company | 100.0% | 100.0% | 2024 |
| Individual | 10.0% | 10.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GARBO SCHROLL INVEST ApS
Schroll Medical ApS Board members of Schroll Medical ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frederik Harald Halberg | Chief Executive Officer | 0 companies |
| Carsten Garbo Schroll | Chief Executive Officer | 0 companies |
| Mariolla Pernille Damborg Dolleris Schroll | Board of Directors | 0 companies |
| Søren Dolleris Schroll | Chairman | 0 companies |
| Stine Garbo Schroll | Board of Directors | 0 companies |